Longzhen Zhang

机构：Nanchang University, Xuzhou Medical College, Affiliated Hospital of Xuzhou Medical College, Northern Jiangsu People's Hospital, First Affiliated Hospital of Nanchang University · ORCID：0000-0002-5786-1560

发表论文 301 篇 · 总被引 5499 次 · h-index 38

代表论文

• First-line zorifertinib for EGFR-mutant non-small cell lung cancer with central nervous system metastases: The phase 3 EVEREST trial (2024 · Med · 被引 16)
• LR-DETR: a lightweight real-time traffic sign detection model based on improved RT-DETR (2025 · Journal of Real-Time Image Processing · 被引 14)
• MoAGL-SA: a multi-omics adaptive integration method with graph learning and self attention for cancer subtype classification (2024 · BMC Bioinformatics · 被引 11)
• Phase 1 trial of SHR-A2102, a nectin-4–directed antibody drug conjugate (ADC), in advanced solid tumors. (2025 · Journal of Clinical Oncology · 被引 6)
• Dalpiciclib (Dalp) plus endocrine therapy (ET) as adjuvant treatment for HR+/HER2– early breast cancer (BC): The randomized, phase 3, DAWNA-A trial. (2025 · Journal of Clinical Oncology · 被引 5)
• ATP11B triggers the infiltration of T cells into GBM and intensifies anti-GBM immunity by upregulating and externalizing S1PR1 (2025 · Journal of Translational Medicine · 被引 4)